Skip to Main Content

Paper Details

Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons.
Clin Infect Dis
55
2023

Datasets

Release 1.2